Modus Advisors’s Moderna MRNA Stock Holding History

Modus Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$413	–	250
2025 Q4	$413	Buy	+14	New	+$380	﹤0.01%	343
2025 Q1	–	Sell	-84	Closed	-$3.49K	–	227
2024 Q4	$3.49K	Buy	+84	New	+$4.01K	﹤0.01%	268
2023 Q3	–	Sell	-1,891	Closed	-$230K	–	101
2023 Q2	$230K	Sell	1,891 -361	-16%	-$48.2K	0.1%	95
2023 Q1	$346K	Sell	2,252 -7	-0.3%	-$1.16K	0.16%	81
2022 Q4	$406K	Hold	2,259	–	–	0.2%	75
2022 Q3	$267K	Buy	2,259 +129	+6%	+$19.6K	0.14%	83
2022 Q2	$304K	Buy	+2,130	New	+$304K	0.15%	81
2021 Q3	–	Sell	-2	Closed	–	–	184
2021 Q2	$0	Buy	+2	New	+$357	﹤0.01%	262

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Modus Advisors's MRNA Position: Q1 2026 in Review

Modus Advisors sold out of Moderna (MRNA) in Q1 2026, closing a stake of 14 shares — an estimated $413 sold.

Modus Advisors first reported a position in MRNA in Q2 2021 and held it in 8 quarters. The position peaked at $406K in Q4 2022. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Modus Advisors reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
Modus Advisors sold 14 Moderna shares in Q1 2026, an estimated $413.
Modus Advisors first reported a position in Moderna in Q2 2021 and held it in 8 quarters.
Modus Advisors's Moderna position peaked at $406K in Q4 2022.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.